Source - GNW

Further strengthening its digital health services portfolio in the

fast-growing US healthcare market 

  • Anthelio brings an additional US$200 million to Atos existing c. US$200 million in healthcare services in North America as well as US$600 million of backlog creating a strong base for growth within this dynamic sector.
  • Anthelio brings recognized industry expertise in the healthcare market along with a full suite of healthcare IT services, IP based revenue cycle management services, and state-of-the-art patient engagement solutions.
  • Anthelio offers a significant base of loyal customers to Atos' existing client base, further expanding the footprint of Atos' North America operations with the addition of more than 1,700 Anthelio employees of which 1,300 are in the U.S.
  •  Following this acquisition, Atos will generate c. US$0.4 billion revenue in healthcare IT with US$2.5 billion revenue in North America, its largest geography.

Bezons, September 12, 2016- Atos, a global leader in digital services, announces having signed a share purchase agreement to acquire Anthelio Healthcare Solutions (Anthelio), the largest independent provider of healthcare technology solutions in North America, for an enterprise value of US$275 million (8.5xEBIT post-synergies in 2017). This acquisition, fully financed by cash, uniquely positions Atos to reach a broader customer base in the U.S. healthcare market by strengthening the scale and scope of its services. The combined organization will support Atos customer's need to better optimize financial performance, improve the patient care experience, engage patients through state-of-the-art applications and address the increasing demands of security, risk and compliance.

Anthelio generates about US$200 million of annual revenue growing at 8%. Thanks to strong revenue synergies, the Group expects the newly formed US healthcare practice to reach double digit organic growth in 2018.

"We are pleased to welcome the Anthelio team to Atos. With their strong and loyal customer base and our combined commitment to providing a world-class customer experience, our ambition with Anthelio is to reinforce our Healthcare footprint in the U.S. and to become the leader in digital healthcare solutions", said Michel-Alain Proch, Group Senior Executive Vice President and CEO North American Operations, Atos. "I am pleased that Asif Ahmad, a recognized leader in the healthcare technology sector, currently CEO of Anthelio Healthcare Solutions, will lead our newly formed healthcare practice in the US."

 "This is an exciting development for Anthelio and its customers," said Asif Ahmad, CEO, Anthelio Healthcare Solutions. "Our vision has always been to drive high value for healthcare organizations by solving complex clinical and business problems. Combining Atos' leadership in global digital services with Anthelio's leadership in Healthcare Technology and Revenue Cycle Management is unprecedented. This acquisition addresses the many core clinical and financial processes that hospitals and physicians are faced with today".

Atos is acquiring Anthelio from Actis, a leading London-based growth markets investment firm, its majority shareholder since November 2010, as well as from McLaren Health Care Corporation, a leading fully integrated health network and the largest customer of Anthelio.

Philip A. Incarnati, President and CEO of McLaren Health Care Corporation said "As a long-time partner of Anthelio, I trust that Atos is the right choice to support McLaren's future growth and digital transformation through our renewed 5-year contract".

Anthelio is recognized by Black Book[*] for its outsourcing services in both HIM (Health Information Management) and IT Infrastructure, and also brings more than 1,700 healthcare professionals to Atos, of which 1,300 are in the U.S and 400 in India.

With strong reputation and quality-driven culture coupled with Atos' proven healthcare digital transformation solutions, this acquisition will provide customers with expanded technology offerings that provide sustainable value in today's evolving healthcare environment.

The intended acquisition received the unanimous support of both the Atos and Anthelio Boards of Directors. The transaction is expected to close before the end of September 2016.




Investor Relations:    Gilles Arditti                  +33 1 73 26 00 66

                                                                        [email protected]

Benoit d'Amécourt        +33 1 73 26 02 27

                                                                        [email protected]


Press:                          Kim Marie Testa            +1 214 223 5343

                                                                        [email protected]



Press:                          John Thompson           +44 207 234 5107

[email protected]


                                    Greenbrook Communications

Georgiana Brunner        +44 207 592 2000

Matthew Goodman       [email protected]

 About Atos

 Atos SE (Societas Europaea) is a leader in digital services with pro forma annual revenue of circa € 12 billion and circa 100,000 employees in 72 countries. Serving a global client base, the Group provides Consulting & Systems Integration services, Managed Services & BPO, Cloud operations, Big Data & Cybersecurity solutions, as well as transactional services through Worldline, the European leader in the payments and transactional services industry. With its deep technology expertise and industry knowledge, the Group works with clients across different business sectors: Defense, Financial Services, Health, Manufacturing, Media, Utilities, Public sector, Retail, Telecommunications, and Transportation.


Atos is focused on business technology that powers progress and helps organizations to create their firm of the future. The Group is the Worldwide Information Technology Partner for the Olympic & Paralympic Games and is listed on the Euronext Paris market. Atos operates under the brands Atos, Atos Consulting, Atos Worldgrid, Bull, Canopy, Unify and Worldline.



For more information, visit:

About Anthelio Healthcare Solutions

Anthelio® is a driving force in the healthcare industry and is the largest independent provider of healthcare technology solutions to hospitals, physician practice groups and other healthcare providers. By provisioning hospitals across the US with innovative solutions in the areas of IT, EHR, HIM, Revenue Cycle Management, Patient Engagement and Enterprise Interoperability (EI), Anthelio impacts quality care to over 60 million patients. The acquisition of Pyramid Healthcare Solutions in 2015 broadened Anthelio's RCM service offerings while expanding its medical coding, coding audit, Clinical Documentation Improvement and HIM outsourcing services. Powered by cutting-edge technologies and thousands of healthcare professionals with extensive clinical and operational experience, Anthelio drives sustainable value to over 63,000 physicians and nurses in hundreds of healthcare organizations supporting their annual revenue of over $67 billion. Anthelio is headquartered in Dallas, Texas with several satellite offices across the US and globally.


For more information, visit:


About Actis

Actis is a leading investor in growth markets, delivering consistent competitive returns, responsibly. It has a growing portfolio of investments across Asia, Africa and Latin America and approximately US$6.3bn assets under management today.


For more information, visit:


This release contains "forward-looking statements" that involve risks and uncertainties, including references concerning the Group's expected growth and profitability in the future which may significantly impact expected performance other than as indicated. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services and potential, and statements regarding future performance. Significant risks and uncertainties may be linked to factors out of the control of the Company and not precisely estimated, such as market conditions or competitors behaviors. Any statements made in this document that are not statements of historical fact, including statements about Atos' beliefs and expectations and statements about Anthelio Healthcare Solutions (Anthelio) and/or Atos' proposed acquisition thereof, are forward-looking statements and should be evaluated as such. Forward-looking statements include statements that may relate to Atos' plans, objectives, strategies, goals, future events, future revenue or synergies, or performance, and other information that is not historical information. Actual events or results may differ from those described in this document due to a number of risks and uncertainties that are described within the 2015 Registration Document filed with the Autorité des Marchés Financiers (AMF) on April 7, 2016 under the registration number: D.16-0300 and its update filed with the Autorité des Marchés Financiers (AMF) on August 4, 2016 under the registration number: D.16-0300-A01. Atos does not undertake, and specifically disclaims, any obligation or responsibility to update or amend any of the information above except as otherwise required by law.

[*]A leading independent research firm in the healthcare industry

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ATOS via Globenewswire